Mario Schootman1, Rebecca Aft, Donna B Jeffe. 1. Division of Health Behavior Research, Department of Medicine, Washington University School of Medicine, St Louis, MO 63108, USA. mschootm@dom.wustl.edu
Abstract
BACKGROUND: The authors examined potential reasons (sociodemographics, psychologic distress, health behavior, chronic health conditions, access to medical care) for increased prevalence of lower-body functional limitations among long-term (> or =5 years) cancer survivors. METHODS: The authors used National Health Interview Survey data from 2005 through 2007, and defined lower-body functional limitation as reporting difficulty/inability to perform at least 1 of 5 activities (walking approximately one-quarter of a mile; walking up and down 10 steps without rest; standing for 2 hours; stooping, crouching, or kneeling; and lifting 10 lbs). Increased prevalence of lower-body functional limitations was compared between long-term survivors of each of 11 cancer types reported by > or =50 respondents (n = 2143) and persons without cancer history (controls; n = 72,618). RESULTS: Among cancer survivors, 57.0% had a lower-body functional limitation versus 26.6% of controls. The unadjusted prevalence of lower-body functional limitations varied by cancer type, ranging from 44.9% (lymphoma survivors) to 88.8% (lung cancer survivors). Long-term lung (odds ratio [OR], 7.91), uterine (OR, 2.41), thyroid (OR, 2.27), cervical (OR, 1.76), ovarian (OR, 1.75), and breast (OR, 1.35) cancer survivors had increased odds of reporting a lower-body functional limitation than controls after adjusting for sociodemographic factors (all P < .05). Differences in the prevalence of arthritis and lower-back pain and in access to medical care explained differences in lower-body functional limitation prevalence between controls and long-term breast, cervical, ovarian, and uterine cancer survivors. Long-term bladder, colorectal, lymphoma, melanoma, and prostate cancer survivors were equally likely to report a lower-body functional limitation as controls. CONCLUSIONS: Treatment of arthritis and lower-back pain and increasing access to medical care might help reduce the risk of lower-body functional limitations and improve quality of life among specific long-term cancer survivors.
BACKGROUND: The authors examined potential reasons (sociodemographics, psychologic distress, health behavior, chronic health conditions, access to medical care) for increased prevalence of lower-body functional limitations among long-term (> or =5 years) cancer survivors. METHODS: The authors used National Health Interview Survey data from 2005 through 2007, and defined lower-body functional limitation as reporting difficulty/inability to perform at least 1 of 5 activities (walking approximately one-quarter of a mile; walking up and down 10 steps without rest; standing for 2 hours; stooping, crouching, or kneeling; and lifting 10 lbs). Increased prevalence of lower-body functional limitations was compared between long-term survivors of each of 11 cancer types reported by > or =50 respondents (n = 2143) and persons without cancer history (controls; n = 72,618). RESULTS: Among cancer survivors, 57.0% had a lower-body functional limitation versus 26.6% of controls. The unadjusted prevalence of lower-body functional limitations varied by cancer type, ranging from 44.9% (lymphoma survivors) to 88.8% (lung cancer survivors). Long-term lung (odds ratio [OR], 7.91), uterine (OR, 2.41), thyroid (OR, 2.27), cervical (OR, 1.76), ovarian (OR, 1.75), and breast (OR, 1.35) cancer survivors had increased odds of reporting a lower-body functional limitation than controls after adjusting for sociodemographic factors (all P < .05). Differences in the prevalence of arthritis and lower-back pain and in access to medical care explained differences in lower-body functional limitation prevalence between controls and long-term breast, cervical, ovarian, and uterine cancer survivors. Long-term bladder, colorectal, lymphoma, melanoma, and prostate cancer survivors were equally likely to report a lower-body functional limitation as controls. CONCLUSIONS: Treatment of arthritis and lower-back pain and increasing access to medical care might help reduce the risk of lower-body functional limitations and improve quality of life among specific long-term cancer survivors.
Authors: Ida J Korfage; Marie-Louise Essink-Bot; Floortje Mols; Lonneke van de Poll-Franse; Roy Kruitwagen; Marjolein van Ballegooijen Journal: Int J Radiat Oncol Biol Phys Date: 2008-09-25 Impact factor: 7.038
Authors: Scott B Patten; Jeanne V A Williams; Dina H Lavorato; Geeta Modgill; Nathalie Jetté; Michael Eliasziw Journal: Gen Hosp Psychiatry Date: 2008-07-23 Impact factor: 3.238
Authors: Brenna E Blackburn; Patricia A Ganz; Kerry Rowe; John Snyder; Yuan Wan; Vikrant Deshmukh; Michael Newman; Alison Fraser; Ken Smith; Kimberly Herget; Jaewhan Kim; Anne C Kirchhoff; Christina Porucznik; Heidi Hanson; Marcus Monroe; Mia Hashibe Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-11-22 Impact factor: 4.254
Authors: Susan K Lutgendorf; Eileen Shinn; Jeanne Carter; Susan Leighton; Keith Baggerly; Michele Guindani; Bryan Fellman; Marianne Matzo; George M Slavich; Marc T Goodman; William Tew; Jenny Lester; Kathleen M Moore; Beth Y Karlan; Douglas A Levine; Anil K Sood Journal: Gynecol Oncol Date: 2017-05-17 Impact factor: 5.482
Authors: Laura Q Rogers; Kerry S Courneya; Stephen J Carter; Philip M Anton; Steven Verhulst; Sandra K Vicari; Randall S Robbs; Edward McAuley Journal: Breast Cancer Res Treat Date: 2016-08-18 Impact factor: 4.872
Authors: Mario Schootman; Anjali D Deshpande; Sandi L Pruitt; Rebecca Aft; Donna B Jeffe Journal: Cancer Causes Control Date: 2010-04-17 Impact factor: 2.506